
Professor Cellular and Translational Cardiology @UMCUtrecht @RMUtrecht @CirculatHealth
Utrecht, the Netherlands
Joined January 2010
- Tweets1.2K
- Following319
- Followers499
- Likes1.9K
Joost Sluijter retweeted
Mice, rats, rabbits, guinea pigs, zebrafish — which one fits your #AtrialFibrillation research question? This #JCTR review is the cheat sheet you didn't know you needed — species, induction methods, induction rates, all in one place. 🫀🐭🐇🐟👉link.springer.com/article/10… @ELaraPezzi
Joost Sluijter retweeted
Joost Sluijter retweeted
💔 #HFpEF is more than a heart issue—it’s a multisystem syndrome driven by inflammation, metabolism & organ crosstalk. Current drugs help some, but precision, multi-organ therapies are the future. Read that in #JCTR #CardioTwitter 👉link.springer.com/article/10… @ELaraPezzi #ISCTR
Joost Sluijter retweeted
Joost Sluijter retweeted
Unraveling the Pathophysiological Mechanisms of Phospholamban R14del Cardiomyopathy: A Comprehensive Overview @jsluijter #AHAJournals ahajrnls.org/3Kgf2BI
Joost Sluijter retweeted
✨ Wondering where the next-gen #Cardiovascular therapies will come from?
💡 Proud to be part of the CARE (Cardiovascular Regenerative & Reparative Medicine) Nucleus, ESC Working Group!
@ESCWGCAREChair #ESCCongress
Join Here...
escardio.org/Working-groups/…
Joost Sluijter retweeted
Improving streamlined remote monitoring in #HF with #HeartLogic: workflow redesign led to a decrease in HeartLogic enablement time and reduction in delayed data transmissions 👉#JCTR link.springer.com/article/10… @ELaraPezzi #ISCTR
Joost Sluijter retweeted
Extracellular vesicles can transform regenerative medicine. Here's why they could enable cardiac repair.
Read our recent editorial in Nanomedicine↓
tandfonline.com/doi/full/10.…
@CircHealth_umcu @JSluijter
Joost Sluijter retweeted
Living human myocardial slices hold translational potential for predicting the reversibility of chemotherapy-induced cardiotoxicity #AHAJournals @jsluijter @jpvantintelen @UMCUtrecht @CirculatHealth @Joost_sluijter ahajrnls.org/3FV4DJi
Joost Sluijter retweeted
#magnesium depletion score #MDS is a novel #CVD risk factor, but is it also and specifically for #PAD? in #JCTR a population study identifies an increased risk for the elderly. Read the data from the National Health and Nutrition Examination Survey 👉link.springer.com/article/10…
Joost Sluijter retweeted
Transplanting cardiac microtissues #CMTs with a triple immunosuppression protocol show better engraftment and longer survival in a #heartInjury model. A promising study just published in #JCTR by @JSluijter's group! link.springer.com/article/10… @ELaraPezzi #ISCTR
Human cardiac microtissues have improved engraftment and survival in the heart upon injection vs single cells! A great collaborative achievement and real pleasure to work with this team. Enjoy reading!
@UMCU_Intl sluijterlab.com
rdcu.be/edunL
Interested in the role of Extracellular Vesicles in the cardiovascular system?
See our recent work to provide a stepping stone towards more understanding!
nature.com/articles/s41569-0…
Joost Sluijter retweeted
🫀 New insights alert! 🚨 Discover how emerging #PostTranslationalModifications are reshaping our understanding of #CVD! Read the cutting-edge science behind it in this #JCTR review: link.springer.com/article/10… #ISCTR @ELaraPezzi
Joost Sluijter retweeted
It's this time of the year! Announcing the best 2024 #JCTR paper: Gut Microbiota as Predictive Biomarker for Chronic Heart Failure in Patients with Different Nutritional Risk by Yang et al. link.springer.com/article/10… Congratulations to the Authors!
Joost Sluijter retweeted
The JCTR Editorial board is also proud to announce the 6 most commended papers of 2024: link.springer.com/article/10… #ISCTR @ELaraPezzi @pjrbarton @JSluijter @SolovevaAnzhela @GuopingLi2 @roddywalsh @LauraIop_UNIPD @SmartNicola @SpringerNature👇👇
Joost Sluijter retweeted
What if you could permanently regulate your #LDL cholesterol levels? Read on #JCTR the promising application of #CRISPRCas9 editing strategy to help prevent atherosclerosis and CVD 👉link.springer.com/article/10… #ISCTR @ELaraPezzi
Joost Sluijter retweeted
Are you interested in extracellular vesicles and CRISPR gene editing? Check out the post-doc position on EV-mediated CRISPR delivery for treating a rare cardiomyopathy @UMCUtrecht
Don’t miss your chance to apply by January 12th!
careersatumcutrecht.com/vaca…
@ISEV_Journals @NLSEV_
Joost Sluijter retweeted
Increased #ECs apoptosis measured by Endothelial Cell‑Derived #ExtracellularVesicles can discriminate Ischemia and non-obstructive coronary artery disease #INOCA endotypes👉link.springer.com/article/10… #JCTR #ISCTR @ELaraPezzi
















